Transaction in Own Shares - Replacement

RNS Number : 2061B
Artemis Alpha Trust PLC
29 September 2022
 

29 September 2022

 

The following amendments have been made to the Purchase of own shares Replacement Announcement released on 28 September 2022 at 17.54 under RNS No 0615B.

 

In the second paragraph, the purchase date which was specified as 09 August 2022 has been amended to reflect the correct purchase date of 16 September 2022.

 

In addition, the stated purchase price of the shares which was incorrectly specified as 337.9 has been amended to reflect the correction in price from the initial 337.19 pence to the amended 293.5 pence.

 

All other details remain unchanged.

 

The full amended text is shown below:   

 

Artemis Alpha Trust plc (the 'Company')

LEI: 549300MQXY2QXEIL3756

Transaction in own shares

The Board of the Company announces that on 16 September 2022 it made a market purchase of 5,000 Ordinary shares of 1 pence each in the capital of the Company representing 0.01% of the current issued Ordinary share capital. The shares were purchased at a price of 293.5 pence per Ordinary share and will be held in treasury.

Following this purchase, the Company's issued share capital comprises 37,260,474 Ordinary shares, of which 4,323,286 are held in treasury. Therefore the total number of shares with voting rights in the Company will be 32,937,188 Ordinary shares.

Total Voting Rights

The above figure (32,937,188)   may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

Artemis Fund Managers Limited 

Company Secretary

Telephone: 0131 225 7300

 

20 September 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFZGZLZLGGZZM
UK 100